Last updated on February 2018

In Utero Alcoholic Exposure: PlGF Biomarker of Fetal Brain Lesions


Brief description of study

This study aims to validate that PLGF is a biomarker of cerebral lesions and therefore of secondary developmental disorders and disabilities that will be best diagnosed at 2 and 6 years of age.

Clinical Study Identifier: NCT03371641

Find a site near you

Start Over

UH ROUEN

Rouen, France
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.